Search
-
GRK2‐ Targeted Knockdown as Therapy for Multiple System Atrophy
(Movement Disorders. vol. 38, n° 7, pp. 1336-1340, 2023-07)Article de revueOpen access -
Staging of progressive supranuclear palsy-Richardson syndrome using MRI brain charts for the human lifespan
(Brain Communications, 2024-02-20)Article de revueOpen access -
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
(Brain - A Journal of Neurology, 2021-12-11)Article de revueOpen access -
The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations
(Movement Disorders. vol. 37, n° 12, pp. 2336-2341, 2022-09-08)Article de revueOpen access -
Amantadine use in the French prospective NS-Park cohort
(Journal of Neural Transmission. vol. 131, n° 7, pp. 799-811, 2024-07-01)Article de revue -
Neurofilament light levels predict clinical progression and death in multiple system atrophy
(Brain - A Journal of Neurology, 2022-07-29)Article de revueOpen access -
Distortion of voiced obstruents for differential diagnosis between parkinson's disease and multiple system atrophy
(Proc. Interspeech 2021, Interspeech Conference, cz, Brno, 2021-08-30)Communication dans un congrès avec actes -
Ambulatory blood pressure and drug treatment for orthostatic hypotension as predictors of mortality in patients with Multiple System Atrophy
(European Journal of Neurology, 2021-12-31)Article de revue -
Genome sequence analyses identify novel risk loci for multiple system atrophy
(Neuron, 2024-05-02)Article de revueOpen access -
Alterations in electrochemical skin conductance as a marker of autonomic dysfunction in multiple system atrophy
(Parkinsonism and Related Disorders. vol. 103, pp. 56-59, 2022-08-28)Article de revueOpen access